Anti-steatotic effects in conjunction with lowering of PNPLA3 mRNA exerted by LXR inverse agonists in human hepatocytes and in rodent models of non-alcoholic fatty liver disease
Kremoser, C, Hambruch, E, Gege, C, Deuschle, U, Kinzel, O, Krol, D.H, Albers, M, Birkel, M
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Fxr Agonism by Gs-9674 Decreases Steatosis and Fibrosis in a Murine Model of Nash
Liles, J.T, Karnik, S, Hambruch, E, Kremoser, C, Birkel, M, Watkins, W.J, Tumas, D, Breckenridge, D, French, D
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
THU-495 - LXR inverse agonists inhibit de novo lipogenesis and reduce intestinal lipid and cholesterol absorption in a NAFLD mouse model
Kremoser, C., Deuschle, U., Gege, C., Kinzel, O., Krol, H.D., Albers, M., Birkel, M., Hambruch, E.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Intravesical administration of 5-aminolevulinic acid (5-ALA): Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX
POPKEN, G, SCHULTZE-SEEMANN, W, SEILER, K.-U, BIRKEL, M, WETTERAUER, U
Published in European journal of clinical pharmacology (01.06.2000)
Published in European journal of clinical pharmacology (01.06.2000)
Get full text
Journal Article
THU-382 - Anti-steatotic effects in conjunction with lowering of PNPLA3 mRNA exerted by LXR inverse agonists in human hepatocytes and in rodent models of non-alcoholic fatty liver disease
Kremoser, C., Hambruch, E., Gege, C., Deuschle, U., Kinzel, O., Krol, D.H., Albers, M., Birkel, M.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
FRI-288 - From Mice to Men – Changes in FGF15/19 Expression and Bile Acid Levels as Sensitive Markers of Pharmacological FXR Activation; Results from Human Phase I and Animal Studies Using the Potent and Selective FXR Agonist Px-102
Hambruch, E., Krol, H., Perović-Ottstadt, S., Hornberger, M., Steeneck, C., Kinzel, O., Deuschle, U., Birkel, M., Kremoser, C.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
FRI-248 - The FXR agonist GS-9674 reduces fibrosis and portal hypertension in a rat model of NASH
Schwabl, P., Budas, G., Hambruch, E., Supper, P., Burnet, M., Liles, J., Sullivan, T., Huntzicker, E., Birkel, M., French, D., Tumas, D., Peck-Radosavljevic, M., Watkins, W., Trauner, M., Breckenridge, D., Kremoser, C., Reiberger, T.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
The FXR agonist GS-9674 reduces fibrosis and portal hypertension in a rat model of NASH
Schwabl, P., Budas, G., Hambruch, E., Supper, P., Burnet, M., Liles, J., Sullivan, T., Huntzicker, E., Birkel, M., French, D., Tumas, D., Peck-Radosavljevic, M., Watkins, W., Trauner, M., Breckenridge, D., Kremoser, C., Reiberger, T.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Relative bioavailability and bioequivalence of a newly developed fixed combination sachet of acetylsalicylic acid and pseudoephedrine compared with a preliminary combination
Lücker, P W, Birkel, M, Hey, B, Loose, I, Schaefer, A
Published in Methods and findings in experimental and clinical pharmacology (01.10.2003)
Published in Methods and findings in experimental and clinical pharmacology (01.10.2003)
Get more information
Journal Article
LXR inverse agonists inhibit de novo lipogenesis and reduce intestinal lipid and cholesterol absorption in a NAFLD mouse model
Kremoser, C., Deuschle, U., Gege, C., Kinzel, O., Krol, H.D., Albers, M., Birkel, M., Hambruch, E.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man
Ehrlich, A, Fuder, H, Hartmann, M, Wieckhorst, G, Timmer, W, Huber, R, Birkel, M, Bliesath, H, Steinijans, V W, Wurst, W, Lücker, P W
Published in European journal of clinical pharmacology (1996)
Published in European journal of clinical pharmacology (1996)
Get more information
Journal Article
The α-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin
FUDER, H, KLEIST, P, BIRKEL, M, EHRLICH, A, EMEKLIBAS, S, MASLAK, W, STRIDDE, E, WETZELSBERGER, N, WIECKHORST, G, LÜCKER, P. W
Published in European journal of clinical pharmacology (1997)
Published in European journal of clinical pharmacology (1997)
Get full text
Journal Article
Pharmacokinetics and relative bioavailability after single dose administration of 25 mg ketoprofen solution as compared to tablets
Stiegler, S, Birkel, M, Jost, V, Lange, R, Lücker, P W, Wetzelsberger, N
Published in Methods and findings in experimental and clinical pharmacology (01.03.1995)
Get more information
Published in Methods and findings in experimental and clinical pharmacology (01.03.1995)
Journal Article
Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients
Pietruck, Frank, Kiel, Gerhard, Birkel, Manfred, Stahlheber-Dilg, Bodo, Philipp, Thomas
Published in Biopharmaceutics & drug disposition (01.05.2005)
Published in Biopharmaceutics & drug disposition (01.05.2005)
Get full text
Journal Article